WordNet

the branch of medicine concerned with the study and treatment of tumors

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 脳腫瘍患者における疾患状態の評価および治療後サーベイランス assessment of disease status and surveillance after treatment in patients with brain tumors

English Journal

Posterior reversible encephalopathy syndrome: a neurologic phenomenon in cancer patients.

Le EM1, Loghin ME.Author information 1Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, P.O. Box 301402, Unit #431, Houston, TX, 77232-1402, USA, emle@mdanderson.org.AbstractPosterior reversible encephalopathy syndrome is a well-recognized entity associated with a variety of benign and malignant conditions. This syndrome typically manifests itself with headache, visual loss, and seizures. Radiographic abnormalities consist of white matter edema involving the posterior parietal and occipital lobes, manifested as increased T2 and fluid-attenuated inversion recovery signal intensity on magnetic resonance imaging. In the last decade, there has been a reported increase in the incidence of posterior reversible encephalopathy syndrome in cancer patients. The diagnosis can be challenging in this patient population. Early recognition and initiation of appropriate therapy with removal of the causative agent is essential in order to prevent permanent neurologic sequelae.
Current oncology reports.Curr Oncol Rep.2014 May;16(5):383. doi: 10.1007/s11912-014-0383-3.
Posterior reversible encephalopathy syndrome is a well-recognized entity associated with a variety of benign and malignant conditions. This syndrome typically manifests itself with headache, visual loss, and seizures. Radiographic abnormalities consist of white matter edema involving the posterior p
PMID 24595679

Role of surgical resection in low- and high-grade gliomas.

Hervey-Jumper SL1, Berger MS.Author information 1Department of Neurological Surgery, University of California, 505 Parnassus Avenue, M779, San Francisco, CA, 94143, USA.AbstractOPINION STATEMENT: Central nervous system tumors are a major cause of morbidity and mortality in the United States. Outside of brain metastasis, low- and high-grade gliomas are the most common intrinsic brain tumors. Low-grade gliomas have a 5- and 10-year survival rate of 97 % and 91 %, respectively, when extent of resection is greater than 90 %. High-grade gliomas are extremely aggressive with the vast majority of patients experiencing recurrence and a median survival of 1 to 3 years. Survival of patients with both low- and high-grade gliomas is enhanced with maximal tumor resection. The pursuit of more aggressive extent of resection must be balanced with preservation of functional pathways. Several innovations in neurosurgical oncology have expanded our understanding of individualized patient neuroanatomy, physiology, and function. Emerging imaging technologies as well as intraoperative techniques have expanded our ability to resect maximal amounts of tumor while preserving essential function. Stimulation mapping of language and motor pathways is well-established for the safe resection of intrinsic brain lesions. Additional techniques including neuro-navigation, fluorescence-guided microsurgery using 5-aminolevulinic acid, intraoperative magnetic resonance imaging, and high-frequency ultrasonography can all be used to improve extent of resection in glioma patients.
Current treatment options in neurology.Curr Treat Options Neurol.2014 Apr;16(4):284. doi: 10.1007/s11940-014-0284-7.
OPINION STATEMENT: Central nervous system tumors are a major cause of morbidity and mortality in the United States. Outside of brain metastasis, low- and high-grade gliomas are the most common intrinsic brain tumors. Low-grade gliomas have a 5- and 10-year survival rate of 97 % and 91 %, respectiv
PMID 24595756

Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients.

Velasco R1, Bruna J, Briani C, Argyriou AA, Cavaletti G, Alberti P, Frigeni B, Cacciavillani M, Lonardi S, Cortinovis D, Cazzaniga M, Santos C, Kalofonos HP.Author information 1Unit of Neuro-Oncology, Hospital Universitari de Bellvitge-ICO Duran i Reynals, , Barcelona, Spain.AbstractOBJECTIVES: Peripheral neuropathy ranks among the most common dose-limiting and disabling side-effect of oxaliplatin (OXA)-based chemotherapy. The aim of this prospective, multicentre study was to define early clinical and neurophysiological markers that may help to identify patients at risk of developing severe, treatment emergent, cumulative OXA-induced peripheral neuropathy (OXAIPN).
Journal of neurology, neurosurgery, and psychiatry.J Neurol Neurosurg Psychiatry.2014 Apr;85(4):392-8. doi: 10.1136/jnnp-2013-305334. Epub 2013 Jun 29.
OBJECTIVES: Peripheral neuropathy ranks among the most common dose-limiting and disabling side-effect of oxaliplatin (OXA)-based chemotherapy. The aim of this prospective, multicentre study was to define early clinical and neurophysiological markers that may help to identify patients at risk of deve
PMID 23813745

Japanese Journal

Trends and Outcomes in the Treatment of Gliomas Based on Data during 2001–2004 from the Brain Tumor Registry of Japan

, ,On Behalf of the Committee of Brain Tumor Registry of Japan Supported by the Japan Neurosurgical Society
Neurologia medico-chirurgica 55(4), 286-295, 2015
The committee of Brain Tumor Registry of Japan (BTRJ) was founded in 1973 and conducts surveys and analyses of incidence, therapeutic methods, and treatment outcomes of primary and metastatic brain tu …
NAID 130005065367

Trends and Outcomes in the Treatment of Gliomas Based on Data during 2001–2004 from the Brain Tumor Registry of Japan

, ,On Behalf of the Committee of Brain Tumor Registry of Japan Supported by the Japan Neurosurgical Society
Neurologia medico-chirurgica advpub(0), 2015
The committee of Brain Tumor Registry of Japan (BTRJ) was founded in 1973 and conducts surveys and analyses of incidence, therapeutic methods, and treatment outcomes of primary and metastatic brain tu …
NAID 130004922327

Eloquent area 近傍悪性グリオーマの手術−最近の進歩

大西丘倫
Neuro
Goal of malignant glioma surgery is to maximally resect the tumor with minimum neurological dysfunction, giving the patients a chance to survive much longer with keeping good quality of life. When mal …
NAID 130005002165

Related Pictures

Pediatric Neuro-oncology Buch portofrei Neuro-Oncology: The Essentials, Third Neuro-Oncology by Jeremy Rees, Patrick Y Genomic & Molecular Neuro-Oncology Neuro-Oncology Fellowship - Massachusetts Neuro-oncology illustration